US FDA to step up enforcement of pharma ads, sends enforcement letters
Summary
The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of let...
The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply with regulations that are already on the books, senior administration officials said on Tuesday.